Monopar Therapeutics
MNPR
$0.60
Share price
-9.38%
Change (1 day)
-30.45%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) - Net assets
Net assets on the balance sheet as of December 2023 : $5.58 M
According to Monopar Therapeutics's latest financial reports the company has $5.58 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Monopar Therapeutics - Net assets on balance sheet (from 2017 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $10.08 M | -46.73% |
| 2021-12-31 | $18.94 M | 20.71% |
| 2020-12-31 | $15.69 M | 24.26% |
| 2019-12-31 | $12.62 M | 82.53% |
| 2018-12-31 | $6.91 M | -28.08% |
| 2017-12-31 | $9.61 M | 239.78% |
| 2016-12-31 | $2.83 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 3,910.33% | 🇺🇸 USA |